CTSA and leukodystrophy: This underlines the limitation of panel sequencing, which unlike WES or WGS, does not allow for future re-analysis of DNA to detect for mutations in leukodystrophy genes that are discovered after initial panel curation (in this case the CLCN2, AARS, CTSA, and RNF216 genes).